Stock OSCR OSCAR HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Oscar Health, Inc.

Equities

OSCR

US6877931096

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-13 pm EDT 		5-day change 1st Jan Change
21.95 USD +1.43% Intraday chart for Oscar Health, Inc. +15.71% +139.89%
May. 09 Goldman Sachs Adjusts Price Target on Oscar Health to $21 From $16, Maintains Neutral Rating MT
May. 07 Sector Update: Health Care Stocks Advance in Late Afternoon Trading MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company is in a robust financial situation considering its net cash and margin position.
  • The stock, which is currently worth 2024 to 0.36 times its sales, is clearly overvalued in comparison with peers.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
OSCAR HEALTH, INC. Stock Oscar Health, Inc.
+139.89% 5.13B -
BUPA ARABIA FOR COOPERATIVE INSURANCE COMPANY Stock Bupa Arabia for Cooperative Insurance Company
+23.06% 10.48B
B-
MEDIBANK PRIVATE LIMITED Stock Medibank Private Limited
+3.93% 6.64B
C+
THE COMPANY FOR COOPERATIVE INSURANCE Stock The Company for Cooperative Insurance
+12.14% 5.96B
C
NIB HOLDINGS LIMITED Stock nib holdings limited
+1.62% 2.39B
B+
TRUPANION, INC. Stock Trupanion, Inc.
+0.85% 1.08B
C
THE MEDITERRANEAN AND GULF COOPERATIVE INSURANCE AND REINSURANCE COMPANY Stock The Mediterranean and Gulf Cooperative Insurance and Reinsurance Company
+93.75% 868M -
C
AMANA COOPERATIVE INSURANCE COMPANY Stock Amana Cooperative Insurance Company
+1.38% 154M - -
PT LIPPO GENERAL INSURANCE TBK Stock PT Lippo General Insurance Tbk
-17.04% 70.96M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. OSCR Stock
  4. Ratings Oscar Health, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW